You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-1028-ESGO Role of radiotherapy in platinum sensitive oligometastatic recurrent ovarian cancer: a valid alternative to delay systemic treatment

Citation Tools

Article menu

Download PDFPDF

Ovarian cancer
2022-RA-1028-ESGO Role of radiotherapy in platinum sensitive oligometastatic recurrent ovarian cancer: a valid alternative to delay systemic treatment
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Bonaldo G, Lazzari R, Durante S, et al
2022-RA-1028-ESGO Role of radiotherapy in platinum sensitive oligometastatic recurrent ovarian cancer: a valid alternative to delay systemic treatment
International Journal of Gynecologic Cancer 2022;32:A290-A291.